FCM
EGRX

Farallon Capital Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History

Farallon Capital Management’s Portfolio EGRX Stock Details EGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-100,000
Closed -$1.27M – 96
2014
Q3 		$1.27M Hold
100,000
– – 0.02% 75
2014
Q2 		$1.43M Hold
100,000
– – 0.02% 86
2014
Q1 		$1.28M Buy
+100,000
New +$1.28M 0.03% 78